nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—F2—Selenium Micronutrient Network—GPX1—Parkinson's disease	0.00523	0.00523	CbGpPWpGaD
Argatroban—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.00505	0.00505	CbGpPWpGaD
Argatroban—F2—Hemostasis—DGKQ—Parkinson's disease	0.00498	0.00498	CbGpPWpGaD
Argatroban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00493	0.00493	CbGpPWpGaD
Argatroban—CYP3A5—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00487	0.00487	CbGpPWpGaD
Argatroban—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00486	0.00486	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—INS—Parkinson's disease	0.00483	0.00483	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—MTHFR—Parkinson's disease	0.00483	0.00483	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00471	0.00471	CbGpPWpGaD
Argatroban—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.00455	0.00455	CbGpPWpGaD
Argatroban—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.00453	0.00453	CbGpPWpGaD
Argatroban—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00451	0.00451	CbGpPWpGaD
Argatroban—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.00449	0.00449	CbGpPWpGaD
Argatroban—CYP3A5—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00445	0.00445	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—IL1B—Parkinson's disease	0.00443	0.00443	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—TAC1—Parkinson's disease	0.0044	0.0044	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—TAC1—Parkinson's disease	0.00434	0.00434	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00431	0.00431	CbGpPWpGaD
Argatroban—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.00416	0.00416	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK8—Parkinson's disease	0.00413	0.00413	CbGpPWpGaD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.004	0.004	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.00393	0.00393	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—FGB—Parkinson's disease	0.00393	0.00393	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.0039	0.0039	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—INS—Parkinson's disease	0.00384	0.00384	CbGpPWpGaD
Argatroban—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.00382	0.00382	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—GRM4—Parkinson's disease	0.00379	0.00379	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—HSPA9—Parkinson's disease	0.00374	0.00374	CbGpPWpGaD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00366	0.00366	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IL1B—Parkinson's disease	0.00361	0.00361	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—PENK—Parkinson's disease	0.00359	0.00359	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.00349	0.00349	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00341	0.00341	CbGpPWpGaD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.0033	0.0033	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—PDYN—Parkinson's disease	0.00328	0.00328	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—Parkinson's disease	0.00327	0.00327	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—TNF—Parkinson's disease	0.00322	0.00322	CbGpPWpGaD
Argatroban—F2—Hemostasis—MAG—Parkinson's disease	0.00321	0.00321	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GSTA4—Parkinson's disease	0.00321	0.00321	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00316	0.00316	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00315	0.00315	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—GRM5—Parkinson's disease	0.00305	0.00305	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—EDN1—Parkinson's disease	0.00302	0.00302	CbGpPWpGaD
Argatroban—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00301	0.00301	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—EDN1—Parkinson's disease	0.00298	0.00298	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00296	0.00296	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—SOD1—Parkinson's disease	0.00291	0.00291	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00291	0.00291	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—IL1B—Parkinson's disease	0.00286	0.00286	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—GPR37—Parkinson's disease	0.00286	0.00286	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—DGKQ—Parkinson's disease	0.00286	0.00286	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—MAOB—Parkinson's disease	0.00286	0.00286	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00286	0.00286	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—IGF2—Parkinson's disease	0.00277	0.00277	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00277	0.00277	CbGpPWpGaD
Argatroban—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00271	0.00271	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.0027	0.0027	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—RPL6—Parkinson's disease	0.00266	0.00266	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.00264	0.00264	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TNF—Parkinson's disease	0.00262	0.00262	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—HGF—Parkinson's disease	0.00261	0.00261	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00261	0.00261	CbGpPWpGaD
Argatroban—F2—Vitamin B12 Metabolism—IL6—Parkinson's disease	0.0026	0.0026	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00259	0.00259	CbGpPWpGaD
Argatroban—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00259	0.00259	CbGpPWpGaD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00258	0.00258	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—ATP6AP2—Parkinson's disease	0.00252	0.00252	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.0025	0.0025	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.0025	0.0025	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.0025	0.0025	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—GRK5—Parkinson's disease	0.00239	0.00239	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00237	0.00237	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—DCTN1—Parkinson's disease	0.00231	0.00231	CbGpPWpGaD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00229	0.00229	CbGpPWpGaD
Argatroban—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00226	0.00226	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—HTR1A—Parkinson's disease	0.00225	0.00225	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—TAC1—Parkinson's disease	0.00222	0.00222	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—DRD1—Parkinson's disease	0.00217	0.00217	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—GRK5—Parkinson's disease	0.00217	0.00217	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—GRM4—Parkinson's disease	0.00214	0.00214	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—CYP2D6—Parkinson's disease	0.00212	0.00212	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—IL6—Parkinson's disease	0.00211	0.00211	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—DRD3—Parkinson's disease	0.00211	0.00211	CbGpPWpGaD
Argatroban—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.0021	0.0021	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00209	0.00209	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—TNF—Parkinson's disease	0.00208	0.00208	CbGpPWpGaD
Argatroban—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00207	0.00207	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VPS35—Parkinson's disease	0.00204	0.00204	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PENK—Parkinson's disease	0.00203	0.00203	CbGpPWpGaD
Argatroban—F2—Hemostasis—FGB—Parkinson's disease	0.00202	0.00202	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—RPL14—Parkinson's disease	0.00202	0.00202	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—RPL23A—Parkinson's disease	0.00202	0.00202	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.002	0.002	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—GRM4—Parkinson's disease	0.00194	0.00194	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—CYP2E1—Parkinson's disease	0.00194	0.00194	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00192	0.00192	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—DRD2—Parkinson's disease	0.0019	0.0019	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—HTR7—Parkinson's disease	0.0019	0.0019	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—RPS8—Parkinson's disease	0.00188	0.00188	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00186	0.00186	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PDYN—Parkinson's disease	0.00185	0.00185	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PENK—Parkinson's disease	0.00184	0.00184	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00175	0.00175	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—GRM5—Parkinson's disease	0.00172	0.00172	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.0017	0.0017	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GPR37—Parkinson's disease	0.00169	0.00169	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—DGKQ—Parkinson's disease	0.00169	0.00169	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PDYN—Parkinson's disease	0.00168	0.00168	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—IL6—Parkinson's disease	0.00168	0.00168	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—COMT—Parkinson's disease	0.00161	0.00161	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GSTP1—Parkinson's disease	0.0016	0.0016	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—MAOA—Parkinson's disease	0.0016	0.0016	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—COMT—Parkinson's disease	0.00159	0.00159	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00158	0.00158	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—GRM5—Parkinson's disease	0.00157	0.00157	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00154	0.00154	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—EDN1—Parkinson's disease	0.00152	0.00152	CbGpPWpGaD
Argatroban—F2—Hemostasis—SOD1—Parkinson's disease	0.0015	0.0015	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.00149	0.00149	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GSTM1—Parkinson's disease	0.00147	0.00147	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00147	0.00147	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00147	0.00147	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00145	0.00145	CbGpPWpGaD
Argatroban—F2—Hemostasis—ABL1—Parkinson's disease	0.00143	0.00143	CbGpPWpGaD
Argatroban—F2—Hemostasis—IGF2—Parkinson's disease	0.00143	0.00143	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.0014	0.0014	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—RIT2—Parkinson's disease	0.00135	0.00135	CbGpPWpGaD
Argatroban—F2—Hemostasis—HGF—Parkinson's disease	0.00135	0.00135	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—HTR2A—Parkinson's disease	0.00133	0.00133	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00133	0.00133	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.00133	0.00133	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GRK5—Parkinson's disease	0.00128	0.00128	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00127	0.00127	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—TAC1—Parkinson's disease	0.00125	0.00125	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—DRD1—Parkinson's disease	0.00123	0.00123	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—DRD3—Parkinson's disease	0.00119	0.00119	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—HTR1A—Parkinson's disease	0.00116	0.00116	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GRM4—Parkinson's disease	0.00115	0.00115	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—TAC1—Parkinson's disease	0.00114	0.00114	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—IGF2—Parkinson's disease	0.00112	0.00112	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—DRD1—Parkinson's disease	0.00112	0.00112	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00111	0.00111	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PENK—Parkinson's disease	0.00109	0.00109	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAG—Parkinson's disease	0.00109	0.00109	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—DRD3—Parkinson's disease	0.00108	0.00108	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—HTR7—Parkinson's disease	0.00108	0.00108	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—DRD2—Parkinson's disease	0.00108	0.00108	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MCCC1—Parkinson's disease	0.00104	0.00104	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ND3—Parkinson's disease	0.00104	0.00104	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00101	0.00101	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PDYN—Parkinson's disease	0.000995	0.000995	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.000987	0.000987	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—OMD—Parkinson's disease	0.000981	0.000981	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—TALDO1—Parkinson's disease	0.000981	0.000981	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—DRD2—Parkinson's disease	0.000977	0.000977	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—HTR7—Parkinson's disease	0.000977	0.000977	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000974	0.000974	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GFAP—Parkinson's disease	0.000935	0.000935	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NDUFB11—Parkinson's disease	0.00093	0.00093	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GRM5—Parkinson's disease	0.000925	0.000925	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000903	0.000903	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000891	0.000891	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GCH1—Parkinson's disease	0.000887	0.000887	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—EDN1—Parkinson's disease	0.000862	0.000862	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000821	0.000821	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FGF20—Parkinson's disease	0.000811	0.000811	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—FBP1—Parkinson's disease	0.000791	0.000791	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GBA—Parkinson's disease	0.000791	0.000791	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—DBH—Parkinson's disease	0.000791	0.000791	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ADORA2A—Parkinson's disease	0.000787	0.000787	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—EDN1—Parkinson's disease	0.000782	0.000782	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000754	0.000754	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000748	0.000748	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—INS—Parkinson's disease	0.000745	0.000745	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000745	0.000745	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000743	0.000743	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000738	0.000738	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000734	0.000734	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—INSR—Parkinson's disease	0.000726	0.000726	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FGB—Parkinson's disease	0.000686	0.000686	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—HTR2A—Parkinson's disease	0.000684	0.000684	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000684	0.000684	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HTR1A—Parkinson's disease	0.000682	0.000682	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000675	0.000675	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TAC1—Parkinson's disease	0.000672	0.000672	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—DRD1—Parkinson's disease	0.000659	0.000659	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—DRD3—Parkinson's disease	0.000638	0.000638	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ADRBK1—Parkinson's disease	0.000596	0.000596	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—DDC—Parkinson's disease	0.000581	0.000581	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—DRD2—Parkinson's disease	0.000577	0.000577	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HTR7—Parkinson's disease	0.000577	0.000577	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTA4—Parkinson's disease	0.000548	0.000548	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PLA2G6—Parkinson's disease	0.000494	0.000494	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MAOB—Parkinson's disease	0.000489	0.000489	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000485	0.000485	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000485	0.000485	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IGF2—Parkinson's disease	0.000484	0.000484	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IGF1R—Parkinson's disease	0.000468	0.000468	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EDN1—Parkinson's disease	0.000462	0.000462	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000456	0.000456	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000456	0.000456	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000432	0.000432	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NGF—Parkinson's disease	0.000425	0.000425	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000413	0.000413	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HTR2A—Parkinson's disease	0.000404	0.000404	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APOE—Parkinson's disease	0.000376	0.000376	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000368	0.000368	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000368	0.000368	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000368	0.000368	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP2D6—Parkinson's disease	0.000363	0.000363	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CTGF—Parkinson's disease	0.000356	0.000356	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP2E1—Parkinson's disease	0.000332	0.000332	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NQO1—Parkinson's disease	0.000328	0.000328	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—TH—Parkinson's disease	0.000324	0.000324	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—INS—Parkinson's disease	0.000321	0.000321	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYCS—Parkinson's disease	0.000311	0.000311	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—COMT—Parkinson's disease	0.000275	0.000275	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTP1—Parkinson's disease	0.000274	0.000274	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MAOA—Parkinson's disease	0.000273	0.000273	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—HMOX1—Parkinson's disease	0.00027	0.00027	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—DDC—Parkinson's disease	0.00027	0.00027	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ABCB1—Parkinson's disease	0.000259	0.000259	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTA4—Parkinson's disease	0.000255	0.000255	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTM1—Parkinson's disease	0.000252	0.000252	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GPX1—Parkinson's disease	0.000241	0.000241	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CASP3—Parkinson's disease	0.000239	0.000239	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL6—Parkinson's disease	0.000238	0.000238	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	0.000229	0.000229	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MAOB—Parkinson's disease	0.000227	0.000227	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—MTHFR—Parkinson's disease	0.000222	0.000222	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MAPK8—Parkinson's disease	0.00022	0.00022	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—APOE—Parkinson's disease	0.000207	0.000207	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—INS—Parkinson's disease	0.000177	0.000177	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	0.000169	0.000169	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CTGF—Parkinson's disease	0.000166	0.000166	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	0.000154	0.000154	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NQO1—Parkinson's disease	0.000153	0.000153	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—TH—Parkinson's disease	0.00015	0.00015	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYCS—Parkinson's disease	0.000144	0.000144	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL6—Parkinson's disease	0.00014	0.00014	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—COMT—Parkinson's disease	0.000128	0.000128	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTP1—Parkinson's disease	0.000127	0.000127	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MAOA—Parkinson's disease	0.000127	0.000127	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—HMOX1—Parkinson's disease	0.000126	0.000126	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ABCB1—Parkinson's disease	0.000121	0.000121	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTM1—Parkinson's disease	0.000117	0.000117	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GPX1—Parkinson's disease	0.000112	0.000112	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—MTHFR—Parkinson's disease	0.000103	0.000103	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—APOE—Parkinson's disease	9.63e-05	9.63e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—INS—Parkinson's disease	8.23e-05	8.23e-05	CbGpPWpGaD
